-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Biora Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2019 to Q2 2024.
- Biora Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$15.8M, a 5.71% decline year-over-year.
- Biora Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$68M, a 16.9% decline year-over-year.
- Biora Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$67.1M, a 8.68% decline from 2022.
- Biora Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$61.8M, a 47.6% increase from 2021.
- Biora Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$118M, a 9.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)